Skip to content

Clinical trials

Phase 4 Neurocognitive Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Phase: Phase 4 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20132
20151
20161
20182
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chiang Mai University1
Flavia orange1
New York State Psychiatric Institute1
Oregon Health and Science University1
Peking University First Hospital1
Second Affiliated Hospital of Wenzhou Medical University1
Sunnybrook Health Sciences Centre1
University Hospital, Basel, Switzerland1
University Hospital, Geneva1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders9
Cognition Disorders3
Cognitive Dysfunction3
Delirium3
Mental Disorders2
Alzheimer Disease1
Anosmia1
Brain Neoplasms1
Confusion1
Dementia1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.